期刊文献+

厄贝沙坦对高血压并阵发性房颤患者P波离散度及心率变异性的影响 被引量:4

Effects of Irbesartan on P Wave Dispersion and Heart Rate Variability in Patient with Hypertension and Paroxysmal Atrial Fibrillation
下载PDF
导出
摘要 目的研究厄贝沙坦对高血压并阵发性房颤患者P波离散度及心率变异性的影响。方法将95例高血压患者分为有房颤组和无房颤组,根据是否应用厄贝沙坦分为用药组及未用药组,分别测定用药前及用药1年后的P波离散度及心率变异性,并与37例健康体检者的指标作比较。结果高血压患者P波离散度高于对照组,心率变异性低于对照组。有房颤组P波离散度高于无房颤组,差异有统计学意义(P<0.05)。用药组P波离散度低于未用药组,差异有统计学意义(P<0.05)。有房颤组的房颤复发次数减少,用药后用药组心率变异性明显升高。结论应用厄贝沙坦可降低P波离散度,改善心率变异性及自主神经功能。 Objective To observe the effect of irbesartan on P wave dispersion (PD) and heart rate wariability (HRV) in the patients with hypertension and paroxysmal atrial fibrillation (PAF). Methods 95 patients with hypertension were divided into 4 groups, PAF group, non- PAF group, irbesarten group and non- irbesartan group according to whether or not complicating PAF and irbesartan treatment. PD and HRV were measured before and after 1- year irbesartan treatment and compared with those in 37 cases of physical examination as the control group. Results PD in the hypertension patients was higher than that in the control group,HRV was lower than that in the control group. PD in the PAF group was higher than that in the non- PAF group with statistical difference between them (P 〈 0. 05). PD in the irbesartan group was lower than that non- irbesartan group with statistical difference between the two groups, the PAF frequency in the PAF group was decreased. After irbesartan treatment, HRV in the irbesartan group was obviously increased. Conclusion Irbesartan can decrease PD,and improve HRV and the autonomic nervous function in the patients with EH.
出处 《中国药业》 CAS 2012年第14期37-39,共3页 China Pharmaceuticals
关键词 厄贝沙坦 高血压 阵发性房颤 P波离散度 心率变异性 irbesartan hypertension paroxysmal atrial fibrillation P wave dispersion heart rate variability
  • 相关文献

参考文献9

  • 1Christiansen EH, Frost L, Pilegaard H, et al. Within - and between - patient variation of the signal - a-eraged P wave in coronary artery dis- ease [ J ]. Pacing Clin Electrophysiol, 1996, 19 (1): 72 - 81.
  • 2Stein PK, Dornitrovich PP, Kleiger RE, et al. Clinical and demographic de- terminants of heart rate variability in patients post myocardial infarction: insights from the cardiac arrhythmia suppression trial(CAST) [J]. Clin Cardiol, 2000, 23(3): 187 - 194.
  • 3刘力生,龚兰生.中国高血压防治指南(试行本)[J].高血压杂志,2000,8(1):94-102. 被引量:945
  • 4延荣强,郑方胜,张庆海.氯沙坦对高血压并阵发性心房颤动病人左心房功能影响[J].齐鲁医学杂志,2009,24(4):348-350. 被引量:6
  • 5郭继鸿.P波离散度[J].临床心电学杂志,1999,8(3):189-192. 被引量:210
  • 6Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation[J]. Am Heart J, 1998, 13(5): 733 -7:38.
  • 7Ciaroni S, Cuenoud L, Bloch A. Clinical study to investigate the predictive parameters for the onset of atr/al fibrillation in patients with essential hy- pertension[J]. Am Heart J, 2000, L39(5): 814 - 819.
  • 8Schauerte P, Scherlag B J, Pitha J, et al. Catheter ablation of cardiac auto- nomic nerves for prevention of vagal atrial fibrillation [J]. Circulation, 2000, 102(2): 2 774 - 2 780.
  • 9Ehrlich JR, Hohnloser SH. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence[J]. Eur Heart J, 2007, 27 (5) : 512 - 518.

二级参考文献8

  • 1WILLEMS R, SIPIDO K R, HOLEMANS P, et al. Different patterns of angiotensin Ⅱ and atrial natriuretic peptide secre tion in a sheep model of atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2001,12 : 1387-1392.
  • 2GOETTE A, STAACK T, ROCKEN C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin converting enzyme in human atria during atrial fibrillation[J]. JAm Coll Cardiol, 2000,35:1669-1677.
  • 3WRIGHT J W, HARDING J W. Brain angiotensin receptor subtypes AT and their functions[J]. Regul Pegul Pept, 1995,59:269.
  • 4AUSMA J, DISPERSYN G D, DUIMEL H, et al. Changes in ultra structural calcium distribute in goat atria during atrial fibrillation [J]. J Mol Cell Cardiol, 2000,32(3):355-364.
  • 5KUMAGAI K, NAKASHIMA H, URATA H, et aI. Effects of angiotensin Ⅱ type Ⅰ receptor antagonist on electrical and structural remodeling in atrial fibrillation[J]. J Am Coll Car diol, 2003,41(12) :2197.
  • 6勇春明,毛拥军.替米沙坦对高血压病人胰岛素抵抗的影响[J].青岛大学医学院学报,2008,44(5):447-448. 被引量:3
  • 7宁险峰,张文忠,刘松,蔡尚郎.缬沙坦后处理对心肌缺血再灌注损伤的保护作用[J].青岛大学医学院学报,2008,44(6):490-492. 被引量:6
  • 8周晓彬,纪新强,徐莉.PPMS 1.5统计软件的功能及其应用[J].青岛大学医学院学报,2009,45(1):91-93. 被引量:284

共引文献1158

同被引文献27

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部